Bausch Health Americas, Inc.

This study tested an oral medication called amiselimod (MT-1303) against a placebo in 322 adults with mild to moderate ulcerative colitis. The goal was to see if the drug could reduce disease activity over 12 weeks, with an option to continue treatment for up to 36 weeks. The tri…

This study tested a new gel called IDP-126 against a standard acne treatment (Epiduo Forte) and a placebo gel. About 686 people with moderate to severe acne used one of the treatments daily for 12 weeks. The goal was to see which gel reduced pimples and cleared skin better.

This study looked at how a prescription lotion (IDP-118) works in children aged 4 to 16 with moderate to severe plaque psoriasis. Researchers measured how much of the drug enters the bloodstream and whether it affects the body's stress hormone system (HPA axis). The goal was to c…

This study tested a medicine called plecanatide in 218 children and teens aged 6 to 18 who have irritable bowel syndrome with constipation (IBS-C). The goal was to see if it helps them have more bowel movements and feel less belly pain compared to a placebo. Participants took the…